SCHEMBL12698681

SCHEMBL12698681

CC(C)(c1ccccc1)N1CCN(C(=O)c2ccc(N)cc2)CC1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA12 O43570 2/20 0.50
▸ CA1 P00915 2/20 0.50
▸ CA2 P00918 2/20 0.50
▸ CA7 P43166 2/20 0.50
▸ CA9 Q16790 2/20 0.50
▸ CA14 Q9ULX7 2/20 0.50
▸ FASN P49327 1/20 0.50
▸ MEN1 O00255 5/20 0.49
▸ KMT2A Q03164 5/20 0.49
▸ SMN1; SMN2 Q16637 2/20 0.49
▸ ALDH1A1 P00352 1/20 0.49
▸ HTT P42858 1/20 0.49
▸ POLB P06746 2/20 0.48
▸ HPGD P15428 1/20 0.48
▸ ALOX15 P16050 1/20 0.48
▸ CYP2B6 P20813 1/20 0.47
▸ LMNA P02545 1/20 0.46
▸ TSHR P16473 1/20 0.46
▸ NPSR1 Q6W5P4 1/20 0.46
▸ RBP4 P02753 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12698679 0.85 CA12 (0.49) CA12CA1CA2CA7CA9
SCHEMBL19562300 0.83 FASN (0.57) CA12CA1CA2CA7CA9
SCHEMBL12698683 0.83 CA12 (0.47) CA12CA1CA2CA7CA9
SCHEMBL15534545 0.82 CA12 (0.58) CA12CA1CA2CA7CA9
SCHEMBL20750373 0.81 NPY2R (0.48) FASNMEN1KMT2ASMN1; SMN2ALDH1A1
SCHEMBL20261717 0.78 CA12 (0.73) CA12CA1CA2CA7CA9
SCHEMBL31542129 0.77 CYP2B6 (0.58) KMT2ASMN1; SMN2ALDH1A1CYP2B6
SCHEMBL20750429 0.76 CA12 (0.51) CA12CA1CA2CA7CA9
SCHEMBL2629513 0.76 BLM (0.60) FASNSMN1; SMN2ALDH1A1POLBHPGD
SCHEMBL1512436 0.75 CA12 (0.65) CA12CA1CA2CA7CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012151452-A1 PYRUVATE KINASE ACTIVATORS FOR USE IN THERAPY AGIOS PHARMACEUTICALS, INC (US) 2012-11-08 — — WO disclosed
WO-2012092442-A1 THERAPEUTIC COMPOUNDS AND COMPOSITIONS AGIOS PHARMACEUTICALS, INC. (US) 2012-07-05 — — WO disclosed
Send feedback